Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Associate Professor of Medicine
Rush Medical College
Attending Physician of Infectious Diseases
Cook County Health and Hospitals System, Chicago, IL

Topics of Professional Interest:
  • HIV co-infections with hepatitis C virus and B virus
  • Metabolic and cardiovascular complications of HIV and antiretroviral therapy
  • HIV in the older population
Current Professional Summary:

Dr Adeyemi is Attending Physician in the Section of Infectious Diseases at Stroger Hospital of Cook County, Chicago. In addition to inpatient and outpatient HIV patient care, she is actively involved in teaching medical students, mid-level providers, residents, and Infectious Diseases fellows.

Her clinical research areas include viral hepatitis co-infection, cardiovascular disease in HIV, and HIV in the aging population. She is active in clinical, patient-oreinted research at the CORE center.  She is also the Co-Director of the CORE Center Hepatitis Clinic.

Committees and Organizations:


  • Member, Infectious Diseases Society of America (2000-Present)
Honors and Awards:
  • Resident of the Year, Department of Internal Medicine, University of Illinois Medical Center, Chicago (1995)
  • ACTG (NIH) Minority Fellow Award (1999-2001)
  • College of Medicine University of Ibadan, Nigeria, MBBS (MD) in Medicine (1992)
  • University of College Hospital, Ibadan, Nigeria, Rotating Internship (1993)
  • UIC Medical Center, Chicago, Residency in Internal Medicine (1995-1998)
  • UIC Medical Center, Chicago, Chief Medical Resident (1998-1999)
  • Rush University Medical Center/Cook County Hospital, Chicago, Fellowship in Infectious Diseases (1999-2001)
Selected Publications:
  1. Falusi OM, Aberg JA. HIV and cardiovascular risk factors. AIDS Read. 2001;11:263-268.
  2. Talwani R, Falusi OM, Mendes de Leon CF, Nerad JL, Rich S, Proia LA, Sha BE, Smith KY, Kessler HA. Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;30:191-195.
  3. Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, Minkoff H, Piessens E, Kovacs A, Anastos K, Cohen MH. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis. 2002;35:1414-1417.
  4. Falusi OM, Pulvirenti J, Sarazine J, Shastri P, Gail C, Glowacki R. HIV-infected inpatients in the HAART era: how do hepatitis C virus coinfected patients differ? AIDS Patient Care STDs. 2003;17:13-16.
  5. Adeyemi OM, Badri SM, Max B, Chinomona N, Barker D. HIV infection in older patients. Clin Infect Dis. 2003;36:1347.
  6. Badri SM, Adeyemi OM, Max BE, Zagorski BM, Barker DE. How does expert advice impact genotypic resistance testing in clinical practice? Clin Infect Dis. 2003;37:708-713.
  7. Adeyemi OM, Max B, Badri SM, Baker DE. Impact of resistance testing ordering guidelines on rates of wild-type virus detection among patients for whom highly active antiretroviral therapy fails. J Acquir Immune Defic Syndr. 2004;35:98-99.
  8. Adeyemi OM, Jensen D, Attar B, Ghaoui R, Gallagher M, Wolen D, Cotler SJ. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection. AIDS Patient Care STDs. 2004;18:239-245.
  9. Adeyemi OM, Pulvirenti J, Perumal S, Mupiddi U, Kohl B, Jezisek T. Cryptococcosis in HIV-infected individuals. AIDS. 2004;18:2218-2219.
  10. Adeyemi OM, Ghaoui R, Attar BM, Jensen D, Cotler SJ. Serologic markers of autoimmunity in hepatitis C infected patients: impact of HIV co-infection. HIV Medicine. 2005 (in press).